Lanolin, Petrolatum Ointment
NDC 69842-488
Product Information
Lanolin, Petrolatum is a OTC MONOGRAPH DRUG-approved product labeled by Cvs Pharmacy, Inc.. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a ointment for topical administration. This product entry covers the primary NDC 69842-488 and 3 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 69842-488?
What are the uses of this product?
What are Active Ingredients of this product?
- LANOLIN 155 mg/g - A yellow fat obtained from sheep's wool. It is used as an emollient, cosmetic, and pharmaceutic aid.
- PETROLATUM 534 mg/g - A colloidal system of semisolid hydrocarbons obtained from PETROLEUM. It is used as an ointment base, topical protectant, and lubricant.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- LANOLIN (UNII: 7EV65EAW6H)
- LANOLIN (UNII: 7EV65EAW6H) (Active Moiety)
- PETROLATUM (UNII: 4T6H12BN9U)
- PETROLATUM (UNII: 4T6H12BN9U) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- COD LIVER OIL (UNII: BBL281NWFG)
- LIGHT MINERAL OIL (UNII: N6K5787QVP)
- MICROCRYSTALLINE WAX (UNII: XOF597Q3KY)
- PARAFFIN (UNII: I9O0E3H2ZE)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 664981 - lanolin 15.5 % / petrolatum 53.4 % Topical Ointment
- RxCUI: 664981 - lanolin 0.155 MG/MG / petrolatum 0.534 MG/MG Topical Ointment
- RxCUI: 664981 - lanolin 15.5 GM per 100 GM / petrolatum 53.4 GM per 100 GM Topical Ointment
* Please review the full disclaimer at the bottom of this page.